Cargando…

“Safety and utility of percutaneous liver biopsy in hematopoietic stem cell transplant pediatric recipients: a retrospective study”

BACKGROUND: Liver biopsies in pediatric hematopoietic stem cell transplantation (HSCT) patients are as and effective when performed at bedside in the Bone Marrow Transplant Unit (BMTU) than in the Day Surgery Unit (DSU), with better patient compliance and lower emotional distress for these children....

Descripción completa

Detalles Bibliográficos
Autores principales: Maximova, Natalia, Gregori, Massimo, Barbieri, Francesca, Pizzol, Antonio, Sonzogni, Aurelio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971751/
https://www.ncbi.nlm.nih.gov/pubmed/27485733
http://dx.doi.org/10.1186/s12885-016-2603-8
_version_ 1782446164347453440
author Maximova, Natalia
Gregori, Massimo
Barbieri, Francesca
Pizzol, Antonio
Sonzogni, Aurelio
author_facet Maximova, Natalia
Gregori, Massimo
Barbieri, Francesca
Pizzol, Antonio
Sonzogni, Aurelio
author_sort Maximova, Natalia
collection PubMed
description BACKGROUND: Liver biopsies in pediatric hematopoietic stem cell transplantation (HSCT) patients are as and effective when performed at bedside in the Bone Marrow Transplant Unit (BMTU) than in the Day Surgery Unit (DSU), with better patient compliance and lower emotional distress for these children. METHODS: The study group consisted of 45 children who underwent allogeneic HSCT. We reviewed 68 liver biopsies performed between April 2006 and September 2015. 12 (17.6 %) biopsies were performed in the DSU and 56 (82.3 %) in the BMTU; nine (13.2 %) prior to HSCT and 59 (86.7 %) after HSCT. Pre-procedural behavioral status (subjective score) was evaluated by pediatric transplant physicians by filling in a questionnaire employing a three-point scale: “calm and cooperative”, “agitated and non-cooperative” or “frightened and suffering”. Objective score was obtained measuring patient’s heart rate before the procedure and comparing it with mean heart rate. RESULTS: Patients who underwent the procedure at the BMTU experienced less emotional distress than those who underwent it in the DSU: 58.3 % of patients treated at the DSU were agitated as compared with 16.1 % of those treated at the BMTU (p < 0.01). Among the 59 biopsies performed after HSCT, 41 (69.5 %) were taken from symptomatic patients for a diagnostic purpose and 18 (30.5 %) in asymptomatic ones in order to rule out hepatic GVHD. Among these 18 procedures, GVHD was diagnosed in 16 (88.9 %) cases. Minor complications occurred in about 17 % of procedures (12 biopsies), at a rate of 25 % for the DSU location compared with 16 % for the BMTU location. Only two major complications were reported, one in the DSU and one in the BMTU. CONCLUSION: Liver biopsy performed at bedside in HSCT patients does not carry a higher risk of adverse events than the same procedure performed in the DSU and has lower emotional distress associated with better patient compliance, thus contributing significantly to a higher standard of care.
format Online
Article
Text
id pubmed-4971751
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49717512016-08-04 “Safety and utility of percutaneous liver biopsy in hematopoietic stem cell transplant pediatric recipients: a retrospective study” Maximova, Natalia Gregori, Massimo Barbieri, Francesca Pizzol, Antonio Sonzogni, Aurelio BMC Cancer Research Article BACKGROUND: Liver biopsies in pediatric hematopoietic stem cell transplantation (HSCT) patients are as and effective when performed at bedside in the Bone Marrow Transplant Unit (BMTU) than in the Day Surgery Unit (DSU), with better patient compliance and lower emotional distress for these children. METHODS: The study group consisted of 45 children who underwent allogeneic HSCT. We reviewed 68 liver biopsies performed between April 2006 and September 2015. 12 (17.6 %) biopsies were performed in the DSU and 56 (82.3 %) in the BMTU; nine (13.2 %) prior to HSCT and 59 (86.7 %) after HSCT. Pre-procedural behavioral status (subjective score) was evaluated by pediatric transplant physicians by filling in a questionnaire employing a three-point scale: “calm and cooperative”, “agitated and non-cooperative” or “frightened and suffering”. Objective score was obtained measuring patient’s heart rate before the procedure and comparing it with mean heart rate. RESULTS: Patients who underwent the procedure at the BMTU experienced less emotional distress than those who underwent it in the DSU: 58.3 % of patients treated at the DSU were agitated as compared with 16.1 % of those treated at the BMTU (p < 0.01). Among the 59 biopsies performed after HSCT, 41 (69.5 %) were taken from symptomatic patients for a diagnostic purpose and 18 (30.5 %) in asymptomatic ones in order to rule out hepatic GVHD. Among these 18 procedures, GVHD was diagnosed in 16 (88.9 %) cases. Minor complications occurred in about 17 % of procedures (12 biopsies), at a rate of 25 % for the DSU location compared with 16 % for the BMTU location. Only two major complications were reported, one in the DSU and one in the BMTU. CONCLUSION: Liver biopsy performed at bedside in HSCT patients does not carry a higher risk of adverse events than the same procedure performed in the DSU and has lower emotional distress associated with better patient compliance, thus contributing significantly to a higher standard of care. BioMed Central 2016-08-02 /pmc/articles/PMC4971751/ /pubmed/27485733 http://dx.doi.org/10.1186/s12885-016-2603-8 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Maximova, Natalia
Gregori, Massimo
Barbieri, Francesca
Pizzol, Antonio
Sonzogni, Aurelio
“Safety and utility of percutaneous liver biopsy in hematopoietic stem cell transplant pediatric recipients: a retrospective study”
title “Safety and utility of percutaneous liver biopsy in hematopoietic stem cell transplant pediatric recipients: a retrospective study”
title_full “Safety and utility of percutaneous liver biopsy in hematopoietic stem cell transplant pediatric recipients: a retrospective study”
title_fullStr “Safety and utility of percutaneous liver biopsy in hematopoietic stem cell transplant pediatric recipients: a retrospective study”
title_full_unstemmed “Safety and utility of percutaneous liver biopsy in hematopoietic stem cell transplant pediatric recipients: a retrospective study”
title_short “Safety and utility of percutaneous liver biopsy in hematopoietic stem cell transplant pediatric recipients: a retrospective study”
title_sort “safety and utility of percutaneous liver biopsy in hematopoietic stem cell transplant pediatric recipients: a retrospective study”
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971751/
https://www.ncbi.nlm.nih.gov/pubmed/27485733
http://dx.doi.org/10.1186/s12885-016-2603-8
work_keys_str_mv AT maximovanatalia safetyandutilityofpercutaneousliverbiopsyinhematopoieticstemcelltransplantpediatricrecipientsaretrospectivestudy
AT gregorimassimo safetyandutilityofpercutaneousliverbiopsyinhematopoieticstemcelltransplantpediatricrecipientsaretrospectivestudy
AT barbierifrancesca safetyandutilityofpercutaneousliverbiopsyinhematopoieticstemcelltransplantpediatricrecipientsaretrospectivestudy
AT pizzolantonio safetyandutilityofpercutaneousliverbiopsyinhematopoieticstemcelltransplantpediatricrecipientsaretrospectivestudy
AT sonzogniaurelio safetyandutilityofpercutaneousliverbiopsyinhematopoieticstemcelltransplantpediatricrecipientsaretrospectivestudy